antagonist representative azilsartan medoxomil and mineralocorticoid receptor antagonist eplerenone to drugs have exhibited pharmacological properties useful
Aldosterone, the mineralocorticoid receptor, and mineralocorticoid receptor antagonists. The traditional view of aldosterone was that it acted primarily as a regulator of sodium, potassium, and water homeostasis.
A mineralocorticoid receptor antagonist (MRA or MCRA) [1] or aldosterone antagonist, is a diuretic drug which antagonizes the action of aldosterone at mineralocorticoid receptors. This group of drugs is often used as adjunctive therapy, in combination with other drugs, for the management of chronic heart failure.
Aldactone is the major brand name drug that functions as a non-specific mineralocorticoid receptor antagonist. The drug's blockage of aldosterone receptors in
A mineralocorticoid receptor antagonist (MRA or MCRA) [1] or aldosterone antagonist, is a diuretic drug which antagonizes the action of aldosterone at mineralocorticoid receptors. This group of drugs is often used as adjunctive therapy, in combination with other drugs, for the management of chronic heart failure.
A mineralocorticoid receptor antagonist (MRA or MCRA) [1] or aldosterone antagonist, is a diuretic drug which antagonizes the action of aldosterone at mineralocorticoid receptors. This group of drugs is often used as adjunctive therapy, in combination with other drugs, for the management of chronic heart failure .
Mineralocorticoid Receptor Antagonists ; Spironolactone, An aldosterone receptor antagonist used to treat edema, hypertension, heart failure, and aldosteronism.
A mineralocorticoid receptor antagonist is a diuretic drug which antagonizes (or blocks) the action of aldosterone at mineralocorticoid receptors.
Aldosterone antagonists (Mineralocorticoid receptor antagonists) (Eplerenone or Spironolactone). These drugs reduce the stress on your heart. They also have a
Comments